Studies on the different metabolic pathways of antipyrine in man. I. Oral administration of 250, 500 and 1000 mg to healthy volunteers.
Authors:
- M DanhofMDM Danhof
- Dd BreimerDBDd Breimer
Open Access
- 1 December 1979
- journal article
- clinical trial
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 8 (6) , 529-537
Abstract
1 The plasma elimination rate of antipyrine, as measured by the salivary concentration decay, and the urinary excretion of antipyrine and its primary metabolites 4-hydroxy-antipyrine, norantipyrine, 3-hydroxymethyl-antipyrine and 3-carboxy-antipyrine was studied in five healthy volunteers, who received 250, 500 and 1000 mg antipyrine orally in a cross-over design.Keywords
This publication has 26 references indexed in Scilit:
- Studies on the Different Metabolic Pathways of Antipyrine in Rats: Influence of Phenobarbital and 3-Methylcholanthrene TreatmentXenobiotica, 1979
- Assay of Antipyrine and Its Primary Metabolites in Plasma, Saliva and Urine by High-Performance Liquid Chromatography and Some Preliminary Results in ManPharmacology, 1979
- Assay of 3-Carboxy-Antipyrine in Urine by Capillary Gas Chromatography with Nitrogen Selective DetectionPharmacology, 1979
- POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MANThe Lancet, 1977
- Factors influencing antipyrine elimination.British Journal of Clinical Pharmacology, 1977
- Correlation of the plasma elimination of antipyrine and the appearance of 4-hydroxy antipyrine in the urine of manBiochemical Pharmacology, 1974
- The Effect of Spironolactone on Antipyrine Metabolism in ManPharmacology, 1973
- Norphenazone, a new metabolite of phenazone in human urineJournal of Pharmacy and Pharmacology, 1973
- Metabolism of Drugs. LXX. Further Study on Antipyrine MetabolismChemical and Pharmaceutical Bulletin, 1971
- III. Ueber des 1‐Phenyl‐2,3 ‐dimethyl‐4‐oxy‐5‐ pyrazolon1) (4‐Oxyantipyrin)European Journal of Organic Chemistry, 1896